摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3,6-二氢-2,5-吡唑啉胆酸 | 77479-03-9

中文名称
3,6-二氢-2,5-吡唑啉胆酸
中文别名
——
英文名称
2,5-(β-carboxyethyl)dihydropyrazine
英文别名
3,6-dihydropyrazine-2,5-dipropanoic acid;2,5-dicarboxyethyl-3,6-dihydropyrazine;3,3'-(3,6-Dihydropyrazine-2,5-diyl)dipropanoic acid;3-[6-(2-carboxyethyl)-2,5-dihydropyrazin-3-yl]propanoic acid
3,6-二氢-2,5-吡唑啉胆酸化学式
CAS
77479-03-9
化学式
C10H14N2O4
mdl
——
分子量
226.232
InChiKey
VYHCBAHHXCYDQC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    469.7±45.0 °C(Predicted)
  • 密度:
    1.38±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    -1.3
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    99.3
  • 氢给体数:
    2
  • 氢受体数:
    6

SDS

SDS:312b5308a881d8a6609d9e0a0f0be190
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    The nonenzymatic cyclic dimerisation of 5-aminolevulinic acid
    摘要:
    The nonenzymatic cyclic dimerisation of 5-aminolevulinic acid (5-ALA) leads to the formation of a pyrazine (3) and, under some circumstances, pseudo-porphobilinogen (1). On the other hand, the enzyme-catalysed process leads to porphobilinogen (PBG). The products of the former reaction were identified from their NMR spectra and mechanisms for their formation are proposed.
    DOI:
    10.1016/s0040-4020(01)80465-8
  • 作为产物:
    描述:
    5-氨基乙酰丙酸盐酸盐氮气 作用下, 以 sodium hydroxide 为溶剂, 以95%的产率得到3,6-二氢-2,5-吡唑啉胆酸
    参考文献:
    名称:
    Degradation mechanism and stability of 5‐aminolevulinic acid
    摘要:
    The physiological substance and precursor of the heme synthesis 5-aminolevulinic acid (ALA) is a promising prodrug for photodiagnosis and photodynamic therapy of epithelial tumors, particularly in urological and gynecological tissues. For the clinical use of this substance, a chemically stable and sterile drug formulation is required. In the present study, degradation mechanism of ALA in aqueous solution and possibilities to improve its stability were examined. A capillary electrophoretic method was developed that was suitable for the quantification of ALA and of two degradation products. The intermediate degradation product was 2, 5-dicarboxyethyl-3,6-dihydropyrazine, which was further oxidized to 2,5-dicarboxyethylpyrazine. The structures of the degradation products were proven by (1)H and (13)C nuclear magnetic resonance spectroscopy. ALA degradation was very efficiently inhibited by adjusting the pH of the aqueous solution to a value <5 and by purging with nitrogen. Additives such as antioxidants did not improve the ALA stability. These results demonstrated that low pH ALA aqueous solution may be one possible dosage form to be considered for market introduction.
    DOI:
    10.1002/1520-6017(200010)89:10<1335::aid-jps11>3.0.co;2-#
点击查看最新优质反应信息

文献信息

  • Reaction of Acetaldehyde with 5-Aminolevulinic Acid &lt;i&gt;via&lt;/i&gt; Dihydropyrazine Derivative
    作者:Toshinori Suzuki、Naoki Yasuhara、Takashi Ueda、Michiyo Inukai、Mitsunobu Mio
    DOI:10.1248/cpb.c14-00694
    日期:——
    (ALA) was incubated with acetaldehyde at neutral pH, a product was generated. This product was identified as 3-ethylpyrazine-2,5-dipropanoic acid (ETPY). ETPY was stable at neutral pH. It has been reported that ALA dimerizes at neutral pH generating 3,6-dihydropyrazine-2,5-dipropanoic acid (DHPY), and subsequently resulting in pyrazine-2,5-dipropanoic acid (PY) by autoxidation. In the present reaction
    当将5-氨基乙酰丙酸(ALA)溶液与乙醛在中性pH下孵育时,生成了产物。该产物被鉴定为3-乙基吡嗪-2,5-二丙酸(ETPY)。ETPY在中性pH下稳定。据报道,ALA在中性pH下二聚,生成3,6-二氢吡嗪-2,5-二丙酸(DHPY),随后通过自氧化反应生成吡嗪-2,5-二丙酸(PY)。在本反应中,由ALA产生的DHPY与乙醛反应,得到ETPY。乙醛注射前3分钟预先给予ALA抑制了乙醛对雄性小鼠的毒性。这些结果表明ALA可用作乙醛的清除剂。
  • Degradation mechanism and stability of 5‐aminolevulinic acid
    作者:A. Bunke、O. Zerbe、H. Schmid、G. Burmeister、H. P. Merkle、B. Gander
    DOI:10.1002/1520-6017(200010)89:10<1335::aid-jps11>3.0.co;2-#
    日期:2000.10
    The physiological substance and precursor of the heme synthesis 5-aminolevulinic acid (ALA) is a promising prodrug for photodiagnosis and photodynamic therapy of epithelial tumors, particularly in urological and gynecological tissues. For the clinical use of this substance, a chemically stable and sterile drug formulation is required. In the present study, degradation mechanism of ALA in aqueous solution and possibilities to improve its stability were examined. A capillary electrophoretic method was developed that was suitable for the quantification of ALA and of two degradation products. The intermediate degradation product was 2, 5-dicarboxyethyl-3,6-dihydropyrazine, which was further oxidized to 2,5-dicarboxyethylpyrazine. The structures of the degradation products were proven by (1)H and (13)C nuclear magnetic resonance spectroscopy. ALA degradation was very efficiently inhibited by adjusting the pH of the aqueous solution to a value <5 and by purging with nitrogen. Additives such as antioxidants did not improve the ALA stability. These results demonstrated that low pH ALA aqueous solution may be one possible dosage form to be considered for market introduction.
  • The nonenzymatic cyclic dimerisation of 5-aminolevulinic acid
    作者:Anthony R Butler、Sharon George
    DOI:10.1016/s0040-4020(01)80465-8
    日期:1992.1
    The nonenzymatic cyclic dimerisation of 5-aminolevulinic acid (5-ALA) leads to the formation of a pyrazine (3) and, under some circumstances, pseudo-porphobilinogen (1). On the other hand, the enzyme-catalysed process leads to porphobilinogen (PBG). The products of the former reaction were identified from their NMR spectra and mechanisms for their formation are proposed.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物